RNA-targeted drugs for heart disease

RNA-targeted drugs work by preventing the synthesis of proteins involved in different diseases. One, called inclisiran (Leqvio), dramatically lowers LDL cholesterol with just two injections per year. Additional RNA-targeted drugs to lower elevated lipoprotein (a) and high blood pressure are currently in late-stage clinical trials.